Canadian Rx drug seizures resume in USA

19 February 2007

Despite a promise by the US Customs and Border Protection Agency last October that it would refrain from confiscating packages of imported prescription drugs from Canada, at least 37 such packages have been reportedly seized in the southern area of the US state of Florida.

According to a report in the South Florida Sun-Sentinel, the buyers of Canadian Internet pharmacy-supplied drugs received notices from the US Food and Drug Administration stating that their packages had been confiscated because the products "appear to be a new drug" which is unapproved by the agency. However, the pharmacists concerned claimed that the drugs supplied included global drug behemoth Pfizer's cholesterol drug Lipitor (atorvastin) and Anglo-Swedish drug major AstraZeneca's Nexium (esomeprazole) proton pump inhibitor, both of which are FDA-approved.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight